Inhibition of VEGF expression by plasmid-based RNA interference in the retinoblastoma cells

Chinese Journal of Ophthalmology

Volumn 43, Issue 6, 2007, Pages 493-498

  Jia, Ren Bing ^a   Fan, Xian Qun ^a   Wang, Xiao Li ^a   Zhang, Xing Qian ^a   Zhang, Ping ^a   Lu, Jian ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Gene therapy; Retinoblastoma; RNA interference; Vascular endothelial growth factor A

Indexed keywords

SMALL INTERFERING RNA; VASCULOTROPIN A;

ARTICLE; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; PLASMID; RETINOBLASTOMA; TUMOR CELL LINE;

CELL LINE, TUMOR; GENETIC VECTORS; HUMANS; PLASMIDS; RETINOBLASTOMA; RNA, SMALL INTERFERING; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 34547880399     PISSN: 04124081     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Pe'er J, Neufeld M, Baras M, et al. Rubeoshs iridis in retinoblastoma: histologic findings and the possible role of vascular endothelial growth factor in its induction. Ophthalmology, 1997, 104:1251-1258.
2. Akiyama H, Tanaka T, Maeno T, et al. Induction of VEGF gene expression by retinoic acid through Sp1-binding sites in retinoblastoma Y79 cells. Invest Ophthalmol Vis Sci, 2002, 43: 1367-1374.
3. Buchler P, Reber HA, Ullrich A, et al. Pancreatic cancer growth is inhibited by blockade of VEGF-RII. Surgery,2003,134:772-782.
4. Ciafre SA, Niola F, Wannenes F, et al. An anti-VEGF ribozyme embedded within the adenoviral VAI sequence inhibits glioblastoma cell angiogenic potential in vitro. J Vasc Res,2004, 41:220-228.
5. Isayeva T, Ren C, Ponnazhagan S. Recombinant adeno-associated virus 2-mediated antiangiogenic prevention in a mouse model of intraperitoneal ovarian cancer. Clin Cancer Res, 2005, 11:1342-1347.
6. Scherer LJ, Rossh JJ. Approaches for the sequence-specific knockdown of mRNA. Nat Biotechnol,2003,21:1457-1465.
7. Ciais D, Cherradi N, Bailly S, et al. Destabilization of vascular endothelial growth factor mRNA by the zinc-finger protein TIS11b. Oncogene,2004,23:8673-8680.
8. Kwon HS, Shin HC, Kim JS. Suppression of vascular endothelial growth factor expression at the transcriptional and post-transcriptional levels. Nucleic Acids Res,2005,33:e74.
9. Wannenes F, Ciafre SA, Niola F, et al. Vector-based RNA interference against vascular endothelial growth factor-A significantly limits vascularization and growth of prostate cancer in vivo. Cancer Gene Ther,2005,12:926-934.
10. Meng F, Ding J, Liu N, et al. Inhibition of gastric cancer angiogenesis by vector-based RNA interference for Raf-1. Cancer Biol Ther,2005,4:113-117.
11. Chan MW, Chu ES, To KF, et al. Quantitative detection of methylated SOCS-1: a tumor suppressor gene, by a modified protocol of quantitative real time methylation-specific PCR using SYBR green and its use in early gastric cancer detection. Biotechnol Lett, 2004,26:1289-1293.
12. Stanley KK, Szewczuk E. Multiplexed tandem PCR: gene profiling from small amounts of RNA using SYBR green detection. Nucleic Acids Res,2005,33:e180.
13. Schiffelers RM, Ansari A, Xu J, et al. Cancer shRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. Nucleic Acids Res,2004,32:e149.
14. Song E, Zhu P, Lee SK, et al. Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors. Nat Biotechnol,2005,23:709-717.